Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA.

BMC Cancer · 2024 · PMC11328413 · PMID 39148033

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

However, in this small subset of early-stage triple negative patients, the predictive and prognostic value of CTCs failed to reach significance.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.